Debate: Surgery vs. Brachytherapy for Intermediate and High-Risk Prostate Cancer- Brachytherapy

แชร์
ฝัง
  • เผยแพร่เมื่อ 30 ก.ย. 2024

ความคิดเห็น • 4

  • @gerard2620
    @gerard2620 9 หลายเดือนก่อน +1

    Little if any mention here about what patients are NOT good candidates for Brachytherapy...such as enlarged prostate, BPH, etc ....too much data and not enough practical information

  • @robertmonroe3678
    @robertmonroe3678 ปีที่แล้ว +1

    Seems pretty logical that if toxicities are minimized, the wider margins available make Brachy (as a 'boost or as monotherapy) a better tool (v surgery) for intermediate and high risk.

  • @iamric23
    @iamric23 10 หลายเดือนก่อน +1

    Just wondering if the seed implants were permanent or temporary, and the risks associated with both.

  • @MrGuitar1458
    @MrGuitar1458 ปีที่แล้ว +1

    You know, you can put all this DATA out there, but all that really matters to the patients is what happens to THEM. Your remark up front that all treatments are toxic is really the bottom line. I do agree that brachytherapy is the way to go if focal therapy is not an option.